The incidence of nosocomial infective endocarditis (IE) has increased in the last 2 years during the COVID-19 pandemic and the patients might present with overlapping symptoms of heartfailure and pneumonia. Simultaneously, COVID-19 is a hypercoagulable disorder that can complicate the postoperative course of a patient undergoing valve replacement. Therefore, the exact pathology of the native valve needs to be evaluated in such patients. We describe a case of a 45-year-old man with a history of non-compressive myelopathy and COVID-19 infection scheduled for aortic valve replacement and subaortic membrane resection. Intraoperative transesophageal echocardiography was instrumental in defining the aortic valve anatomy that changed the management plan.gggAortic valve replacement, Infective endocarditis, Transesophageal echocardiography.
展开▼